SCH-1681027

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSCH-1681027
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Rhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerckSchering - Plough Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncSchering - Plough Sa
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Rhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A